P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/REFRACTORY SETTING
Mahek Garg,
Justin Puckett,
Sachin Kamal-Bahl,
Monika Raut,
Katherine Ryland,
Samhita Chakraborty,
Jalpa Doshi,
Scott Huntington
Affiliations
Mahek Garg
1 Merck & Co., Inc.
Justin Puckett
2 COVIA Health Solutions
Sachin Kamal-Bahl
2 COVIA Health Solutions
Monika Raut
1 Merck & Co., Inc.
Katherine Ryland
1 Merck & Co., Inc.
Samhita Chakraborty
1 Merck & Co., Inc.
Jalpa Doshi
3 Perelman School of Medicine at the University of Pennsylvania
